User menu

Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes.

Bibliographic reference Catafau, Ana M ; Tolosa, Eduardo ; Vander Borght, Thierry ; et. al. Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes.. In: Movement disorders : official journal of the Movement Disorder Society, Vol. 19, no.10, p. 1175-82 (2004)
Permanent URL http://hdl.handle.net/2078.1/123346
  1. Brooks D. J., Playford E. D., Ibanez V., Sawle G. V., Thompson P. D., Findley L. J., Marsden C. D., Isolated tremor and disruption of the nigrostriatal dopaminergic system: An 18F-dopa PET study, 10.1212/wnl.42.8.1554
  2. Cohen, Arch Neurol, 60, 405 (2003)
  3. Hughes A. J., Daniel S. E., Lees A. J., Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease, 10.1212/wnl.57.8.1497
  4. Rajput A.H., Rozdilsky B., Rajput Alex, Accuracy of Clinical Diagnosis in Parkinsonism — A Prospective Study, 10.1017/s0317167100031814
  5. Hughes, J Neurol Neurosurg Psychiatry, 55, 181 (1992)
  6. Quinn N., Fortnightly Review: Parkinsonism--recognition and differential diagnosis, 10.1136/bmj.310.6977.447
  7. Meara, Age Ageing, 28, 99 (1999)
  8. Kaufman, Synapse, 9, 43 (1991)
  9. Niznik, J Neurochem, 56, 192 (1991)
  10. Neumeyer, J Med Chem, 37, 558 (1994)
  11. Booij, Synapse, 27, 183 (1997)
  12. Booij, J Nucl Med, 40, 753 (1999)
  13. Benamer, Mov Disord, 15, 503 (2000)
  14. Booij, Eur J Nucl Med, 28, 266 (2001)
  15. Radiology Support Devices Inc. Striatal phantom for SPECT, PET and MRI. 1904 E. Dominguez St., Long Beach, CA 90810, USA.
  16. Lokkegaard, Eur J Nucl Med, 29, 1623 (2002)
  17. Jankovic, Arch Neurol, 57, 369 (2000)
  18. Larsen, Acta Neurol Scand, 89, 242 (1994)